Home › Funds › TANG CAPITAL MANAGEMENT LLC › VKTX

TANG CAPITAL MANAGEMENT LLC position in VKTX

VIKING THERAPEUTICS INC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 500,000 shares of VKTX (VIKING THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$16.3M, representing 0.75% of its reported portfolio and ranking #28 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed VKTX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)500.00K sh
Reported value held$16.30M
Portfolio Weight0.75%
First reportedQ1 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's VKTX position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in VKTX in Q1 2024 at 100,000 shares (US$8.2M). The position peaked in Q3 2025 at 870,000 shares, worth US$22.9M. Across 11 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 500,000 shares valued at US$16.3M. Notable position changes include a 167% increase in Q4 2024 (shares fell 40% over the following quarter), a 135% increase in Q3 2025 (shares rose 34% over the following quarter), a 43% trim in Q4 2025 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 100.00K $8.20M New
Q2 2024 120.00K $6.36M Add
Q3 2024 120.00K $7.60M Hold
Q4 2024 320.00K $12.88M Add
Q1 2025 270.00K $6.52M Reduce
Q2 2025 370.00K $9.80M Add
Q3 2025 870.00K $22.86M Add
Q4 2025 500.00K $17.59M Reduce
Q1 2026 500.00K $16.27M Hold
Q2 2026 500.00K $19.50M Hold
Q3 2026 500.00K $16.30M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in VKTX — the largest reported positions include Context Capital Management, LLC (US$39.9M), Eversept Partners, LP (US$32.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held VKTX?

TANG CAPITAL MANAGEMENT LLC has disclosed VKTX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is TANG CAPITAL MANAGEMENT LLC's current position in VKTX?

As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 500.00K shares of VKTX (VIKING THERAPEUTICS INC), valued at $16.30M, representing 0.75% of its reported portfolio and ranking #28.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling VKTX?

In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in VKTX. The position peaked in Q3 2025 at 870.00K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Context Capital Management, LLC, Eversept Partners, LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.